University of Antwerp, UA, Belgium

Scientific contact person: Prof. Herman Goossens
Institute: Vaccine & Infectious Disease Institute

 

Description of the Institute
The University of Antwerp is among the leading research led European universities on the
management of respiratory tract infections; it houses research teams with expertise relevant to the project in antibiotic use and resistance, molecular diagnostics, primary care research, and economic evaluation of vaccination. The Department of Medical Microbiology co-ordinates several international projects financed by the European Commission (NAACAP: QLK2-2000-0294, DG RTD, 200; PROSAFE: QLRT-2000-01273, DG RTD, 2000; ESAC: SI2.325736 / 2001CVG4-016, DG SANCO, 2001; GRACE: LSH-2004-2.1.2)

Qualifications and contribution to the project
Herman Goossens is the head of the department for Microbiology both at the University and in the University hospital. He is also a professor of microbiology at the University of Leiden, the Netherlands. Herman Goossens is an authority on antibiotic use, resistance and molecular diagnostics and has published his research in over 300 full papers in peer-reviewed scientific journals, has written 17 chapters in textbooks and presented his research in more than 350 lectures. He holds several expert positions at the Belgian government, European Commission, World Health Organisation, Food and Drug Administration and Centers for Disease Control of the USA. On Belgian level: vice-Chair of the National Coordination Commission on Antibiotic Policies in Humans and Animals. On European level: co-ordinating microbiologist for Belgium of the European Antimicrobial Resistance Surveillance System (EARSS); expert of the DGXXIV /B1 Scientific Working Group on Antimicrobial Resistance; expert of the Working Group of the Scientific Committee for Animal Nutrition of DGVI; member of the Advisory Board of the EU Conference in Copenhagen ”The Microbial Threat” in 1998. At the WHO level: expert of the WHO Conference on the Medical Impact of the use of Antimicrobial Drugs in Food Animals in Berlin (1997); chair of the WHO Conference on the Use of Quinolones in Food Animals and Potential Impact on Human Health in Geneva (1998). He is the co-ordinator of several European projects, including the European Surveillance of Antibiotic Consumption (ESAC, DG SANCO, 2001-2003), and the Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe (GRACE, DG Research, 2005) and participates in a number of other EC projects. Herman Goossens organised the European Conference on Antibiotic Use in 2001 on behalf of the Belgian EU Presidency, and the Workshop on Educational campaigns held in Brussels (23–24th September 2004).

Samuel Coenen is primary care researcher on lower respiratory tract infections, including quantitative and qualitative studies. He is involved in the analysis of antibiotic registration in primary care, linked with indication and guidelines in Europe, and has conducted studies on the implementation of guidelines. Samuel Coenen is member of the ESAC and GRACE Management Team.
Niels Adriaensses is trained in Medicine. He is a primary care researcher on lower respiratory tract infections, conducting studies on the use of antibiotics.
Sibyl Anthierens is a primary care research specialised in prescribing behaviour and qualitative methodologies.  She is working in close collaboration with GRACE WP10b in order to analysis the process evaluation (WP7 CHAMP) of the WP 10b intervention.

Herman Goossens will lead WP7. Samuel Coenen, Niels Adriaenssens and Sibyl Anthierens will participate in WP7 (The overall objective of WP 7 is to study the feasibility of the implementation of the behavioural change program and possible problems associated with measuring antibiotic use in the different national settings).

Scientific contact person: Prof. Herman Goossens
Institute: Vaccine & Infectious Disease Institute

 

Description of the Institute
The University of Antwerp is among the leading research led European universities on the
management of respiratory tract infections; it houses research teams with expertise relevant to the project in antibiotic use and resistance, molecular diagnostics, primary care research, and economic evaluation of vaccination. The Department of Medical Microbiology co-ordinates several international projects financed by the European Commission (NAACAP: QLK2-2000-0294, DG RTD, 200; PROSAFE: QLRT-2000-01273, DG RTD, 2000; ESAC: SI2.325736 / 2001CVG4-016, DG SANCO, 2001; GRACE: LSH-2004-2.1.2)

Qualifications and contribution to the project
Herman Goossens is the head of the department for Microbiology both at the University and in the University hospital. He is also a professor of microbiology at the University of Leiden, the Netherlands. Herman Goossens is an authority on antibiotic use, resistance and molecular diagnostics and has published his research in over 300 full papers in peer-reviewed scientific journals, has written 17 chapters in textbooks and presented his research in more than 350 lectures. He holds several expert positions at the Belgian government, European Commission, World Health Organisation, Food and Drug Administration and Centers for Disease Control of the USA. On Belgian level: vice-Chair of the National Coordination Commission on Antibiotic Policies in Humans and Animals. On European level: co-ordinating microbiologist for Belgium of the European Antimicrobial Resistance Surveillance System (EARSS); expert of the DGXXIV /B1 Scientific Working Group on Antimicrobial Resistance; expert of the Working Group of the Scientific Committee for Animal Nutrition of DGVI; member of the Advisory Board of the EU Conference in Copenhagen ”The Microbial Threat” in 1998. At the WHO level: expert of the WHO Conference on the Medical Impact of the use of Antimicrobial Drugs in Food Animals in Berlin (1997); chair of the WHO Conference on the Use of Quinolones in Food Animals and Potential Impact on Human Health in Geneva (1998). He is the co-ordinator of several European projects, including the European Surveillance of Antibiotic Consumption (ESAC, DG SANCO, 2001-2003), and the Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe (GRACE, DG Research, 2005) and participates in a number of other EC projects. Herman Goossens organised the European Conference on Antibiotic Use in 2001 on behalf of the Belgian EU Presidency, and the Workshop on Educational campaigns held in Brussels (23–24th September 2004).

Samuel Coenen is primary care researcher on lower respiratory tract infections, including quantitative and qualitative studies. He is involved in the analysis of antibiotic registration in primary care, linked with indication and guidelines in Europe, and has conducted studies on the implementation of guidelines. Samuel Coenen is member of the ESAC and GRACE Management Team.
Niels Adriaensses is trained in Medicine. He is a primary care researcher on lower respiratory tract infections, conducting studies on the use of antibiotics.
Sibyl Anthierens is a primary care research specialised in prescribing behaviour and qualitative methodologies.  She is working in close collaboration with GRACE WP10b in order to analysis the process evaluation (WP7 CHAMP) of the WP 10b intervention.

Herman Goossens will lead WP7. Samuel Coenen, Niels Adriaenssens and Sibyl Anthierens will participate in WP7 (The overall objective of WP 7 is to study the feasibility of the implementation of the behavioural change program and possible problems associated with measuring antibiotic use in the different national settings).

Herman Goossens

 

Sibyl Anthierens, Samuel Coenen and Niels Adriaenssens